secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monopar Therapeutics (MNPR)
CIK:        0001645469
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0001437749-23-018753
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Monopar Therapeutics stockholders elect six directors and ratify BPM LLP as auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected with >8.7M for votes each; broker non-votes ~1.65M.
- Ratification of BPM LLP as independent auditor passed with 10,529,760 for, 3,071 against.
- Total shares represented 10,561,932 out of 13,222,055 entitled, ~80% turnout.
- No other matters were submitted to a vote at the meeting.
- Directors include Starr, Robinson, Brown, Anderson, Klausner, Tsuchimoto.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645469/000143774923018753/0001437749-23-018753-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645469/000143774923018753/mnpr20230627_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-018753

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer